President Donald Trump has said the 200,000 US deaths from coronavirus were “a shame” in response to a reporter’s question about the milestone in the country’s fight against the pandemic. As Trump was departing for an election campaign event in Pittsburgh he told the media: “I think if we didn’t do it properly and do it right, you’d have 2.5 million deaths.”
US President Donald Trump has denied downplaying the seriousness of Covid-19, despite admitting in a recorded interview to having done that. At a televised event with voters, Mr Trump said he had “up-played” it. The claim contradicts comments Mr Trump made to journalist Bob Woodward earlier this year, when he said he minimized the virus’s severity to avoid panic.
The World Health Organization (WHO) has recorded a record one-day rise in the number of new coronavirus infections, with 307,930 reported over 24 hours. The agency said that deaths rose by more than 5,500, bringing the global total to 917,417. The biggest increases in infections were reported in India, the US and Brazil. Worldwide there have been more than 28 million confirmed cases, half of which have been in the Americas.
Delivering a COVID-19 vaccine around the world will require at least 8,000 jumbo jets, a trade body has warned. The International Air Transport Association (IATA) is urging governments to begin planning now to ensure a vaccine reaches populations in every corner of the globe. The IATA warns delivering the vaccine will be the “mission of the century” for the aviation industry.
AstraZeneca Plc on Tuesday said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine because of an unexplained illness in a study participant. The vaccine, developed with the University of Oxford, has been widely seen as one of the leading global candidates against the coronavirus, and the suspension of the trial dims prospects for a potential year-end rollout its lead developer had signaled earlier.
India displaced Brazil on Monday to take second place after the United States in terms of coronavirus infections, with 90,082 new cases whose numbers are expected to grow, while some cities re-opened underground train services shuttered for months. India says its rising infections also reflect higher rates of testing nationwide. The death toll of 71,642 in India compares with nearly 193,000 in the United States and 126,000 in Brazil.
India leads global rise in new weekly cases. Overall global new deaths in the past seven days fell by 3% compared to the previous week, the WHO reported. Tens of millions of pupils returned to school across Europe. AstraZeneca has expanded its agreement with cell therapy firm Oxford Biomedica to mass-produce its COVID-19 potential vaccine, as it looks to scale-up supply ahead of a possible U.S. fast-track approval.
A 33-year-old man living in Hong Kong had Covid-19 twice this year, according to preliminary research. He had symptoms the first time around, but no obvious symptoms the second time, the team at the University of Hong Kong reported Monday. The pre-print study — which the University of Hong Kong said has been accepted for publication in the journal Clinical Infectious Diseases — found that the man’s second case of Covid-19 occurred 142 days after the first.
Daily deaths due to Covid-19 on Tuesday surpassed 1,000 for the first time in the US since the start of June, as Donald Trump admitted the crisis would “get worse” before it got better. The seven-day average for the number of deaths in the country has been slowly rising this month, and went past the 1,000 mark on Tuesday, taking US fatalities to more than 142,000.
The boss of a drugs company that has agreed to deliver up to 100 million doses of a potential COVID-19 vaccine to the UK has told Sky News there is a more than 50% chance of it reaching patients. Thomas Lingelbach, chief executive of France-based Valneva, also told Sky’s Ian King Live that he did not believe the drug would be widely available before the middle of next year.